EUCTR2015-001077-40-NO进行中（未招募）1 期
INNOVATIVE STEROID TREATMENT TO REDUCE ASTHMA DEVELOPMENT IN CHILDREN AFTER FIRST-TIME RHINOVIRUS INDUCED WHEEZING – THE INSTAR STUDY - INSTAR
适应症
相关药物
试验速览
- 阶段
- 1 期
- 状态
- 进行中（未招募）
- 入组人数
- 280
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •1) Age 3-24 months,
- •2) first acute severe wheezing episode,
- •3) rhinovirus positive PCR-test in nasopharyngeal aspirate
- •4) written informed consent.
- •Are the trial subjects under 18? yes
- •Number of subjects for this age range: 280
- •F.1.2 Adults (18-64 years) no
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) no
- •F.1.3.1 Number of subjects for this age range
排除标准
- •1) Previous episodes of expiratory breathing difficulties
- •2) gestational age <= 36 weeks4
- •3) Chronic illness other than atopy (eczema)
- •4) previous systemic or inhaled corticosteroid treatment
- •5) COVID-19 and/or SARS-CoV-2 positive PCR-test in nasopharyngeal secrete
- •6) participation to another trial
- •7) varicella infection or contact during the last 2-3 weeks
- •8) need for intensive care unit treatment, except for respiratory support with high frequency nasal cannula ventilation
研究者
相似试验
进行中（未招募）
1 期
Asthma prevention in high-risk children by using early corticosteroid interventioFirst acute wheezing episodeEUCTR2015-001077-40-SESt. Olavs Hospital280
进行中（未招募）
1 期
Asthma prevention in high-risk children by using early corticosteroid interventioFirst acute wheezing episodeEUCTR2015-001077-40-FITurku University Hospital280
招募中
4 期
Innovative Steroid Treatment to Reduce Asthma Development in Children After First-time Rhinovirus Induced WheezingInflammationAsthmaNCT03889743St. Olavs Hospital280
已完成
不适用
Options to control asthma by means of a newly developed FeNO device for use at homeAsthmaJ45DRKS00029118Bosch Healthcare Solutions GmbH87
已完成
不适用
Asthma Reduction with Inhaled corticoSteroids in Children with a high risk for the development of asthma (At RISC)AsthmaISRCTN58244066Care and Public Health Research Institute (CAPHRI), University Maastricht (Netherlands)97